NCT03092895 2026-01-29A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTCJiangsu HengRui Medicine Co., Ltd.Phase 2 Completed157 enrolled 17 charts